Cancer Vaccines Market to Grow at a 23.7%CAGR Forecast to 2022

PUNE, INDIA, October 10, 2016 /EINPresswire.com/ -- Summery
According to researchers, the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth.

Request a sample report @ https://www.wiseguyreports.com/sample-request/674315-cancer-vaccines-global-market-outlook-2016-2022

North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.
Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC.

Disease Indication Covered:
• Cervical cancer
• Esophageal cancer
• Liver cancer
• Prostate cancer
• Lung cancer
• Breast cancer
• Stomach cancer
Technologies Covered:
• Inactivated Vaccines
• Peptide/protein vaccines
• Synthetic Vaccines
• Toxoid Vaccines
• Live Attenuated Vaccines
• Recombinant Vector Vaccines
• Antigen vaccines
• Dendritic Cell Vaccines
• Subunit Vaccines
• Heat shock protein vaccines
• DNA- and vector-based vaccines
• Conjugate Vaccines
• Anti-idiotype vaccines
• Cancer stem cell vaccines
End Users Covered:
• Adults
• Paediatrics

Vaccine Types Covered:
• Therapeutic Vaccines
• Preventive Vaccines
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=674315

Table of Contents
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Cancer Vaccines Market, By Disease Indication
5.1 Introduction
5.2 Cervical cancer
5.3 Esophageal cancer
5.4 Liver cancer
5.5 Prostate cancer
5.6 Lung cancer
5.7 Breast cancer
5.8 Stomach cancer

6 Global Cancer Vaccines Market, By Technology
6.1 Introduction
6.2 Inactivated Vaccines
6.3 Peptide/protein vaccines
6.4 Synthetic Vaccines
6.5 Toxoid Vaccines
6.6 Live Attenuated Vaccines
6.7 Recombinant Vector Vaccines
6.8 Antigen vaccines
6.9 Dendritic Cell Vaccines
6.10 Subunit Vaccines
6.11 Heat shock protein vaccines
6.12 DNA- and vector-based vaccines
6.13 Conjugate Vaccines
6.14 Anti-idiotype vaccines
6.15 Cancer stem cell vaccines

7 Global Cancer Vaccines Market, By End User
7.1 Introduction
7.2 Adults
7.3 Pediatrics

8 Global Cancer Vaccines Market, By Vaccine Type
8.1 Therapeutic Vaccines
8.2 Preventive Vaccines

9 Global Cancer Vaccines Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Oxford BioMedica
11.2 Vaccinogen Inc.
11.3 GlaxoSmithKline
11.4 Sanofi India Limited-P.P. Enterprises
11.5 Juvaris Biotherapeutics
11.6 Merk&co
11.7 Prima BioMed Ltd
11.8 Cytos Biotechnology AG
11.9 Ubivac
11.10 duro BioTech
11.11 AstraZeneca plc
11.12 MedImmune, LLC
11.13 Nova Rx Corporation
11.14 Argos Therapeutics
11.15 Prima BioMed Ltd

Complete report details @ https://www.wiseguyreports.com/reports/674315-cancer-vaccines-global-market-outlook-2016-2022

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.